Receptor Tryosine Kinase Inhibitors as Potent Weapons in War Against Cancers
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
758-776
Author(s):
P. Sapra Sharma, R. Sharma and T. Tyagi
Cytokine/Antibody Complexes: An Emerging Class of Immunostimulants
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
809-825
Author(s):
Sven Mostbock
Molecular Signature of HPV-Induced Carcinogenesis: pRb, p53 and Gene Expression Profiling
Journal:
Current Genomics
Volume:
10
Page:
26-34
Author(s):
Agueda Buitrago-Perez, Guillermo Garaulet, Ana Vazquez-Carballo, Jesus M. Paramio and Ramon Garcia-Escudero
New Approaches to Target the Androgen Receptor and STAT3 for Prostate Cancer Treatments
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
9
Page:
395-400
Author(s):
Meilan He and Charles Y.F. Young
Synthesis and Hypoxia Selective Radiosensitization Potential of β-2-FAZA and β-3-FAZL: Fluorinated Azomycin β-Nucleosides
Journal:
Medicinal Chemistry
Volume:
5
Page:
118-129
Author(s):
P. Kumar, S. Emami, Z. Kresolek, J. Yang, A. J.B. McEwan and L. I. Wiebe
Glucans as Biological Response Modifiers
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
9
Page:
67-75
Author(s):
M. Novak and V. Vetvicka
Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
9
Page:
84-107
Author(s):
M. W. Lawless, S. Norris, K. J. O'Byrne and S. G. Gray
Targeting the Immune System in Cancer
Journal:
Current Pharmaceutical Biotechnology
Volume:
10
Page:
166-184
Author(s):
Devyani Chaudhuri, Robert Suriano, Abraham Mittelman and Raj K. Tiwari
The Discovery of Antiangiogenic Molecules: A Historical Review
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
345-352
Author(s):
Domenico Ribatti
From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of Cancer
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
9
Page:
221-229
Author(s):
Isabelle Dussault and Steven F. Bellon